Effect of serotonergic system on AVP secretion induced by physical exercise

Neuropeptides

Volumn 44, Issue 1, 2010, Pages 53-56

  Coiro, V ^a,b   Maffei, M L ^a,b   Volta, E ^a,b   Cataldo, S ^a,b   Minelli, R ^a,b   Vacca, P ^a,b   Volpi, R ^a,b   Chiodera, P ^a,b  

^a UNIVERSITY OF PARMA   (Italy)

^b Parma Hospital   (Italy)

Author keywords

AVP secretion; Physical exercise; Serotonin

Indexed keywords

ARGIPRESSIN; BUSPIRONE; ONDANSETRON; SEROTONIN 1A RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; SUMATRIPTAN;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; EXHAUSTION; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VASOPRESSIN RELEASE;

ADULT; ARGININE VASOPRESSIN; BLOOD GLUCOSE; BUSPIRONE; EXERCISE; HEMODYNAMICS; HUMANS; MALE; ONDANSETRON; OSMOLAR CONCENTRATION; SEROTONIN; SEROTONIN AGONISTS; SUMATRIPTAN; YOUNG ADULT;

EID: 73549094452     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.10.004     Document Type: Article

References (12)

1. Akavich P.F., Rieg T.S., Ahamed I., and Lautero J.J. Fluoxetin induces vasopressin and oxytocin abnormalities in food restricted rats given voluntary exercise: relationship to anorexia nervosa. Brain Res. 612 (1993) 180-189
2. Bagdy G., Sved A.F., Murphy D.L., and Szemered K. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma subtypes: renin activity responses to serotonin agonists. Eur. J. Pharmacol. 210 (1992) 285-289
3. Chiodera P., Volpi R., Capretti L., Caffarri G., Magotti M.G., and Coiro V. Different effects of the serotonergic agonist buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycaemia in humans. Neuropeptides 30 (1996) 187-192
4. Gibbs D.M., and Vale W. Effect of serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal-portal blood. Brain Res. 280 (1983) 176-179
5. Holmes M.C., Renzo G.D., Becford L.I., Gillman B., and Jones M.T. Role of serotonin in the control of secretion of corticotropin releasing factor. J. Endocrinol. 93 (1982) 151-160
6. Iovino M., and Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur. J. Phrmacol. 113 (1985) 99-103
7. Meensen R., Watson P., Hasegawa H., Roelands B., and Piacentini M.F. Central fatigue. The serotonin hypothesis and beyond. Sport Med. 36 (2006) 881-909
8. Pergola P.E., Sved A.F., Voogt J.L., and Alper R.H. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 57 (1993) 550-558
9. Rivier C., and Vale W. Neuroendocrine interaction between corticotropin releasing factor and vasopressin on adrenocorticotropin hormone secretion in the rat. In: Schrier R.W. (Ed). Vasopressin (1985), Raven Press, New York 181-188
10. Thompson C.J., Jones I.R., Walker M., Baylis P.H., and Kendall Taylor P. The effects of the specific serotonin antagonist ICI 169-369 on the pituitary hormone response to insulin-induced hypoglycemia in humans. Clin. Endocrinol. 36 (1992) 235-240
11. Van der Kar L.D. Neuroendocrine pharmacology of serotonergic (%-HT) neurons. Ann. Rev. Pharmacol. Toxicol. 31 (1991) 187-320
12. Volpi R., Chiodera P., Giuliani N., Capretti L., Caffarri G., Magotti M.G., and Coiro V. 5-HT3 serotonergic receptor mediation of hypoglycaemia-induced arginine-vasopressin but not oxytocin secretion in normal men. J. Endocrinol. Invest. 21 (1998) 7-11